Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Bernardo Guzmán-Herrador

Biographic Data

ID7789331
NAMEBernardo Guzmán-Herrador
GIVEN NAMESBernardo
FAMILY NAMEGuzmán-Herrador
SIGNATUREGUZMÁN-HERRADOR B
AFFILIATIONSNorwegian Institute of Public Health
ORCID0000-0003-4726-9210
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Informes Sobre La Situación Epidemiológica en Zona Dana en La Comunitat Valenciana, Octubre 2024

    Open Access•Francesc Botella Quijal, A López Maside et al.•ARTICLE•Gaceta Sanitaria•2025

  • Risk Factors for Multidrug-Resistant Gram-Negative Bacteria Carriage upon Admission to the Intensive Care Unit

    Open Access•Nicolás Francisco Fernández‐martínez, Sheila Cárcel et al.•ARTICLE•International Journal of…•2022

    Multidrug-resistant Gram-negative bacteria (MDR-GNB) are microorganisms that have acquired resistance to extended-spectrum antibacterials and constitute an emerging threat to public health. Although carriers are an important source of transmission in healthcare settings, data about risk factors for MDR-GNB carriage are limited. Therefore, we aimed to identify risk factors for MDR-GNB carriage upon intensive care unit (ICU) admission and to optimi…

  • Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España

    Open Access•Rafael Ruiz-Montero, David Epstein et al.•ARTICLE•Gaceta Sanitaria•2020

    Bexsero® (4CMenB), vacuna contra el meningococo B, fue autorizada en Europa en 2013. En España, a pesar de que el meningococo B es la principal causa de enfermedad meningocócica invasiva (EMI), Bexsero® está recomendada y financiada para pacientes con alto riesgo de EMI pero no de forma sistemática en el calendario vacunal del SNS. Evaluar el coste-utilidad, el impacto epidemiológico y los costes totales de la introducción de 4CMenB para una polí…

  • Description of the largest cluster of tuberculosis notified in Norway 1997–2011

    Open Access•Bernardo Guzmán-Herrador, Bernardo R Guzman Herrador et al.•ARTICLE•BMC Public Health•2015

    Most cases in cluster X with available results of TB-screening were already infected at arrival, indicating that their disease could be due to endogenous reactivation, rather than recent transmission after arrival to Norway. TB-status upon arrival was unknown for many of the other immigrants due to lack of initial screening. The reasons why conduction of the initial screening among other immigrants is failing should be explored and methods to sim…

No prominent works on this page.

  • Description of the largest cluster of tuberculosis notified in Norway 1997–2011

    Open Access•Bernardo Guzmán-Herrador, Bernardo R Guzman Herrador et al.•ARTICLE•BMC Public Health•2015

    Most cases in cluster X with available results of TB-screening were already infected at arrival, indicating that their disease could be due to endogenous reactivation, rather than recent transmission after arrival to Norway. TB-status upon arrival was unknown for many of the other immigrants due to lack of initial screening. The reasons why conduction of the initial screening among other immigrants is failing should be explored and methods to sim…

  • Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España

    Open Access•Rafael Ruiz-Montero, David Epstein et al.•ARTICLE•Gaceta Sanitaria•2020

    Bexsero® (4CMenB), vacuna contra el meningococo B, fue autorizada en Europa en 2013. En España, a pesar de que el meningococo B es la principal causa de enfermedad meningocócica invasiva (EMI), Bexsero® está recomendada y financiada para pacientes con alto riesgo de EMI pero no de forma sistemática en el calendario vacunal del SNS. Evaluar el coste-utilidad, el impacto epidemiológico y los costes totales de la introducción de 4CMenB para una polí…

  • Risk Factors for Multidrug-Resistant Gram-Negative Bacteria Carriage upon Admission to the Intensive Care Unit

    Open Access•Nicolás Francisco Fernández‐martínez, Sheila Cárcel et al.•ARTICLE•International Journal of…•2022

    Multidrug-resistant Gram-negative bacteria (MDR-GNB) are microorganisms that have acquired resistance to extended-spectrum antibacterials and constitute an emerging threat to public health. Although carriers are an important source of transmission in healthcare settings, data about risk factors for MDR-GNB carriage are limited. Therefore, we aimed to identify risk factors for MDR-GNB carriage upon intensive care unit (ICU) admission and to optimi…

  • Informes Sobre La Situación Epidemiológica en Zona Dana en La Comunitat Valenciana, Octubre 2024

    Open Access•Francesc Botella Quijal, A López Maside et al.•ARTICLE•Gaceta Sanitaria•2025

Medicine (3 works) · Public health (2 works) · Antibiotic Resistance in Bacteria (1 work) · Antibiotic Use and Resistance (1 work) · Bacteria (1 work) · Bacterial Infections and Vaccines (1 work) · Biology (1 work) · Biostatistics (1 work) · Carriage (1 work) · Cluster (spacecraft (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae